Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D000091362
http://purl.bioontology.org/ontology/MESH/D000091362
|
|---|---|
| Preferred Name | PCSK9 Inhibitors |
| Definitions |
Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.
|
| Synonyms |
Cardiovascular, PCSK9 Inhibitors
Inhibitors, Cardiovascular PCSK9
PCSK9 Inhibitors Cardiovascular
Cardiovascular PCSK9 Inhibitors
PCSK9 Inhibitors, Cardiovascular
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level. |
|---|---|
| altLabel |
Cardiovascular, PCSK9 Inhibitors
Inhibitors, Cardiovascular PCSK9
PCSK9 Inhibitors Cardiovascular
Cardiovascular PCSK9 Inhibitors
PCSK9 Inhibitors, Cardiovascular
|
| prefLabel | PCSK9 Inhibitors
|
| Machine permutation | 2022
|
| HN | 2022
|
| type | |
| tui | T121
|
| TERMUI |
T001106564
T001106565
T001108329
|
| TH | NLM (2022)
|
| MMR | 20220101
|
| notation | D000091362
|
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| DX | 20220101
|
| cui |
C5544467
C5445109
|
| DC | 1
|
| MN |
D27.505.519.186.071.202.685
D27.505.519.389.745.800.506
D27.505.954.557.500.202.685
|
| AQL | AD AE AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
| Inverse of RB | 0
|
| Inverse of isa | |
| MDA | 20210518
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |